Back to News
Market Impact: 0.6

Mizuho raises CrowdStrike stock price target on strong ARR growth

CRWDFLEXMFGRJFTFC
Technology & InnovationCybersecurity & Data PrivacyCorporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Company FundamentalsAnalyst EstimatesAnalyst Insights
Mizuho raises CrowdStrike stock price target on strong ARR growth

Mizuho raised its price target on CrowdStrike (CRWD) to $450 from $425, maintaining a Neutral rating, after the company reported annual recurring revenue of $4.44 billion, a 22% year-over-year increase. While ARR slightly exceeded expectations, revenue was in line with forecasts. The company also announced a $1 billion share repurchase authorization; however, analyst ratings are mixed, with some firms raising price targets and others downgrading the stock due to valuation concerns despite the company's strong growth and demand for its Falcon Flex platform.

Analysis

CrowdStrike Holdings (CRWD) reported robust annual recurring revenue (ARR) of $4.44 billion, representing a 22% year-over-year increase, which narrowly surpassed analyst and market expectations. For its fiscal first quarter 2026, the company announced earnings per share of $0.73, exceeding estimates, while revenue increased 20% year-over-year to $1.1 billion, though this revenue figure slightly missed consensus expectations. Management has guided for continued ARR growth exceeding 20% year-over-year for the second fiscal quarter, indicative of sustained demand for its Falcon Flex platform and strong contract renewals. Complementing this operational strength, evidenced by a gross profit margin of 74.92%, CrowdStrike also announced a $1 billion share repurchase authorization. Despite these positive indicators and a 42.85% year-to-date stock appreciation, pushing it near its 52-week high, analyst sentiment is mixed. Mizuho, for example, raised its price target to $450 but maintained a Neutral rating, primarily due to valuation concerns, a sentiment echoed by InvestingPro analysis which suggests the company is overvalued at its $121.74 billion market capitalization. While some firms like Raymond James (PT $485, Outperform) and Truist Securities (PT $500, Buy) issued more bullish updates, Canaccord Genuity downgraded the stock to Hold, albeit with a raised price target of $475, citing a balanced risk/reward scenario.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.